Click here for a flyer to post in your lab.

Moderator:

David Scadden, MD
Co-Director, HSCI
Co-Chair, Dept. of Stem Cell and Regenerative Biology, Harvard University
Gerald and Darlene Jordan Professor of Medicine, Harvard Medical School
Director, MGH Center for Regenerative Medicine

Program Abstract:
The use of mesenchymal cells clinically continues to attract considerable attention and controversy.  Resolving the proper role of these cells in medicine requires sound pre-clinical biology, highly targeted clinical investigation and the ability to define the basis for observed clinical effects.  This session will discuss where the pre-clinical studies are currently and where select clinical trials are moving forward in our academic community.  A goal of this session is to define how the HSCI community can meaningfully contribute to the further development of this field.

Discussants:

B. Taylor Thompson, MD
Director, Medical Intensive Care Unit, MGH
Professor of Medicine, Havard Medical School

 
Jayaraj Rajagopal, MD
Assistant Professor, Dept. of Medicine, Harvard Medical School
Prinicpal Faculty, HSCI and Center for Regenerative Medicine, MGH

Joseph Bonventre, MD, PhD
Director, Renal Division, BWH
Samuel A. Levine Professor of Medicine, Harvard Medical School
Principal Faculty, HSCI

Commentary:
Robert Sackstein, MD, PhD
Associate Scientific Director, Bone Marrow Transplant Program, BWH
Associate Professor, Havard Medical School
Principal Faculty, HSCI

Jeffrey Karp, PhD
Co-director of Regenerative Therapeutics, Department of Medicine,
Brigham and Women's Hospital and Harvard Medical School
Principal Faculty, HSCI
Harvard-MIT Division of Health Sciences and Technology

Jerome Ritz, MD
Professor of Medicine, Harvard Medical School
DIrector, Connell O'Reilly Cell Manipulation and Gene Transfer Laboratory, Dana-Farber Cancer Institute
Principal Faculty, HSCI

Networking reception to follow (5:00-6:00 p.m.)